Advances in the application of elastography in noninvasive diagnosis of liver fibrosis in nonalcoholic fatty liver disease

Meng LU; Mingjie WANG; Li CHEN

doi:10.3969/j.issn.1001-5256.2023.02.025

Volume 39 Issue 2

Feb. 2023

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(2): 408-412

PDF( 1876 KB)

Advances in the application of elastography in noninvasive diagnosis of liver fibrosis in nonalcoholic fatty liver disease

DOI: 10.3969/j.issn.1001-5256.2023.02.025

Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201801, China

More Information

Corresponding author: CHEN Li, drchenli@163.com (ORCID: 0000-0001-8492-1963)
Received Date: 2022-06-22
Accepted Date: 2022-07-28
Published Date: 2023-02-20

Abstract

Abstract

Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease, and liver fibrosis is closely associated with the prognosis in NAFLD; therefore, accurate assessment of liver fibrosis is of great importance. Liver biopsy is the gold standard for the diagnosis of NAFLD, but its clinical application is limited by invasiveness. Elastography technique based on ultrasound and magnetic resonance imaging has gradually been applied in the diagnosis of liver fibrosis associated with NAFLD. This article elaborates on the principles of the two techniques, compares their respective advantages and disadvantages, and introduces the advances in application in combination with artificial intelligence.
- Elasticity Imaging Techniques,
- Non-alcoholic Fatty Liver Disease,
- Liver Cirrhosis,
- Diagnosis

FullText(HTML)

References(23)

References

[1]	YOUNOSSI ZM, KOENIG AB, ABDELATIF D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64(1): 73-84. DOI: 10.1002/hep.28431.
[2]	CHALASANI N, YOUNOSSI Z, LAVINE JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology, 2018, 67(1): 328-357. DOI: 10.1002/hep.29367.
[3]	TARGHER G, TILG H, BYRNE CD. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach[J]. Lancet Gastroenterol Hepatol, 2021, 6(7): 578-588. DOI: 10.1016/S2468-1253(21)00020-0.
[4]	SIDDIQUI MS, VUPPALANCHI R, van NATTA ML, et al. Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease[J]. Clin Gastroenterol Hepatol, 2019, 17(1): 156-163. e2. DOI: 10.1016/j.cgh.2018.04.043.
[5]	EDDOWES PJ, SASSO M, ALLISON M, et al. Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease[J]. Gastroenterology, 2019, 156(6): 1717-1730. DOI: 10.1053/j.gastro.2019.01.042.
[6]	BOURSIER J, HAGSTRÖM H, EKSTEDT M, et al. Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events[J]. J Hepatol, 2022, 76(5): 1013-1020. DOI: 10.1016/j.jhep.2021.12.031.
[7]	KENNEDY P, WAGNER M, CASTÉRA L, et al. Quantitative elastography methods in liver disease: current evidence and future directions[J]. Radiology, 2018, 286(3): 738-763. DOI: 10.1148/radiol.2018170601.
[8]	PETTA S, WAI-SUN WONG V, BUGIANESI E, et al. Impact of obesity and alanine aminotransferase levels on the diagnostic accuracy for advanced liver fibrosis of noninvasive tools in patients with nonalcoholic fatty liver disease[J]. Am J Gastroenterol, 2019, 114(6): 916-928. DOI: 10.14309/ajg.0000000000000153.
[9]	WONG VW, IRLES M, WONG GL, et al. Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease[J]. Gut, 2019, 68(11): 2057-2064. DOI: 10.1136/gutjnl-2018-317334.
[10]	MÓZES FE, LEE JA, SELVARAJ EA, et al. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis[J]. Gut, 2022, 71(5): 1006-1019. DOI: 10.1136/gutjnl-2021-324243.
[11]	TAPPER EB, LOOMBA R. Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(5): 274-282. DOI: 10.1038/nrgastro.2018.10.
[12]	LOOMBA R, WOLFSON T, ANG B, et al. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study[J]. Hepatology, 2014, 60(6): 1920-1928. DOI: 10.1002/hep.27362.
[13]	ALLEN AM, SHAH VH, THERNEAU TM, et al. The role of three-dimensional magnetic resonance elastography in the diagnosis of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery[J]. Hepatology, 2020, 71(2): 510-521. DOI: 10.1002/hep.30483.
[14]	JAYAKUMAR S, MIDDLETON MS, LAWITZ EJ, et al. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase Ⅱ trial of selonsertib[J]. J Hepatol, 2019, 70(1): 133-141. DOI: 10.1016/j.jhep.2018.09.024.
[15]	AJMERA VH, LIU A, SINGH S, et al. Clinical utility of an increase in magnetic resonance elastography in predicting fibrosis progression in nonalcoholic fatty liver disease[J]. Hepatology, 2020, 71(3): 849-860. DOI: 10.1002/hep.30974.
[16]	YIN M, GLASER KJ, TALWALKAR JA, et al. Hepatic MR elastography: clinical performance in a series of 1377 consecutive examinations[J]. Radiology, 2016, 278(1): 114-124. DOI: 10.1148/radiol.2015142141.
[17]	PARK CC, NGUYEN P, HERNANDEZ C, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease[J]. Gastroenterology, 2017, 152(3): 598-607. e2. DOI: 10.1053/j.gastro.2016.10.026.
[18]	IMAJO K, HONDA Y, KOBAYASHI T, et al. Direct comparison of US and MR elastography for staging liver fibrosis in patients with nonalcoholic fatty liver disease[J]. Clin Gastroenterol Hepatol, 2022, 20(4): 908-917. e11. DOI: 10.1016/j.cgh.2020.12.016.
[19]	SERRA-BURRIEL M, GRAUPERA I, TORÁN P, et al. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia[J]. J Hepatol, 2019, 71(6): 1141-1151. DOI: 10.1016/j.jhep.2019.08.019.
[20]	DINANI AM, KOWDLEY KV, NOUREDDIN M. Application of artificial intelligence for diagnosis and risk stratification in NAFLD and NASH: the state of the art[J]. Hepatology, 2021, 74(4): 2233-2240. DOI: 10.1002/hep.31869.
[21]	WONG GL, YUEN PC, MA AJ, et al. Artificial intelligence in prediction of non-alcoholic fatty liver disease and fibrosis[J]. J Gastroenterol Hepatol, 2021, 36(3): 543-550. DOI: 10.1111/jgh.15385.
[22]	LIU F, GOH GB, TINIAKOS D, et al. qFIBS: An automated technique for quantitative evaluation of fibrosis, inflammation, ballooning, and steatosis in patients with nonalcoholic steatohepatitis[J]. Hepatology, 2020, 71(6): 1953-1966. DOI: 10.1002/hep.30986.
[23]	SARVESTANY SS, KWONG JC, AZHIE A, et al. Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study[J]. Lancet Digit Health, 2022, 4(3): e188-e199. DOI: 10.1016/S2589-7500(21)00270-3.

Relative Articles

[1]	Gangde ZHAO, Simin GUO, Qing XIE, Honglian GUI. Diagnostic accuracy of FibroScan-AST score in nonalcoholic steatohepatitis with significant activity and fibrosis[J]. Journal of Clinical Hepatology, 2022, 38(6): 1288-1292. doi: 10.3969/j.issn.1001-5256.2022.06.014
[2]	Zhiran YANG, Linheng WANG, Yuan LI, Fusheng LIU, Yu WANG, Jianfang WANG, Runhua CHEN. Diagnostic value of transient elastography in the staging of hepatic fibrosis in patients with autoimmune liver disease: A Meta-analysis[J]. Journal of Clinical Hepatology, 2022, 38(1): 97-103. doi: 10.3969/j.issn.1001-5256.2022.01.015
[3]	Shiyan YAN, Jiangao FAN. Diagnosis and treatment of hepatocellular carcinoma associated with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(8): 1748-1752. doi: 10.3969/j.issn.1001-5256.2021.08.002
[4]	Jianpeng LIU, Zhongjie YU, Hanxiao WANG, Wenxia ZHAO. Performance of controlled attenuation parameter measured by FibroScan in the diagnosis of nonalcoholic fatty liver disease and its association with traditional Chinese medicine syndrome types[J]. Journal of Clinical Hepatology, 2021, 37(12): 2869-2873. doi: 10.3969/j.issn.1001-5256.2021.12.026
[5]	Kaimin SONG, Jun LIU. Advances in the application of transient elastography in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2021, 37(2): 419-424. doi: 10.3969/j.issn.1001-5256.2021.02.036
[6]	Mingjie YAO, Xiajie WEN, Leijie WANG, Qiong HE, Jianwen LUO, Jiangao FAN, Qing XIE, Chengwei CHEN, Qing Chun FU, Jun Ping SHI, Yongfeng YANG, Yun XU, Lungen LU, Fengmin LU. Establishment of a model for evaluating the severity of nonalcoholic fatty liver disease based on transient elastography parameters[J]. Journal of Clinical Hepatology, 2021, 37(7): 1614-1618. doi: 10.3969/j.issn.1001-5256.2021.07.027
[7]	Gong Hang, Li LiangPing. Value of Fibroscan combined with GPR,APRI,NFS or FIB-4 for progressive liver fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(3): 541-545. doi: 10.3969/j.issn.1001-5256.2020.03.014
[8]	Liu LinXiang, Nie Yuan, Zhu Xuan. Clinical application of transient elastography in liver cirrhosis and its complications[J]. Journal of Clinical Hepatology, 2020, 36(6): 1362-1365. doi: 10.3969/j.issn.1001-5256.2020.06.037
[9]	Zhu HongMei, Wang QinYing. Advances in the diagnosis and treatment of nonalcoholic fatty liver disease-related liver fibrosis[J]. Journal of Clinical Hepatology, 2020, 36(1): 178-181. doi: 10.3969/j.issn.1001-5256.2020.01.042
[10]	Chen WeiTing, Li ShuangJie. Clinical value of transient elastography,aspartate aminotransferase-to-platelet ratio index,and fibrosis-4 in the diagnosis of liver fibrosis in children with biliary atresia[J]. Journal of Clinical Hepatology, 2020, 36(3): 546-550. doi: 10.3969/j.issn.1001-5256.2020.03.015
[11]	Luo WenPing, Ma Hong, Wang Yu. Advances in the application of transient elastography in noninvasive diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2019, 35(3): 635-639. doi: 10.3969/j.issn.1001-5256.2019.03.041
[12]	Feng Gong, Han HaiJing, Qi Xue, Mi Man, Tian QiuMei, Niu ChunYan. Establishment of a noninvasive diagnosis equation for nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2018, 34(6): 1264-1267. doi: 10.3969/j.issn.1001-5256.2018.06.026
[13]	Xu FengMing, Sheng QingShou. Research advances in serum markers and transient elastography in the evaluation of liver fibrosis[J]. Journal of Clinical Hepatology, 2018, 34(3): 618-622. doi: 10.3969/j.issn.1001-5256.2018.03.040
[14]	Hong Jia, Shi YiWen, Wu XiaoNing, You Hong. Application value of imaging diagnosis in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2018, 34(12): 2698-2701. doi: 10.3969/j.issn.1001-5256.2018.12.041
[15]	Dong Xue, Huang LiPing. Research advances in the value of ultrasound elastography in the diagnosis of gastroesophageal varices in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2424-2427. doi: 10.3969/j.issn.1001-5256.2018.11.035
[16]	Zhuang XiaoFang, Sun Jie, Wang XiaoBo, Wang Yan, Wu QiQi, Wang XiaoZhong. Performance of transient elastography in diagnosis of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2366-2371. doi: 10.3969/j.issn.1001-5256.2017.12.022
[17]	Zhang XiaoTong, Guo LiPing. Value of ultrasonic elastography in diagnosis of liver diseases[J]. Journal of Clinical Hepatology, 2016, 32(11): 2210-2213. doi: 10.3969/j.issn.1001-5256.2016.11.048
[18]	Yang MingLei, Yao DingKang. Application of magnetic resonance elastography as a non-invasive technique for diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2016, 32(3): 588-592. doi: 10.3969/j.issn.1001-5256.2016.03.042
[19]	Zhang GuoSheng, Wang TianYi, Xu YouQing, Zhou Li, Geng Nan, Chen Yu. Diagnostic value of real-time tissue elastography for liver fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(7): 616-619. doi: 10.3969/j.issn.1001-5256.2014.07.010
[20]	Chen Fei, Yao YaNing, Ma SuMei, Feng Fei, Zou Quan, Xue LiLi. Diagnostic value of acoustic radiation force impulse in patients with non- alcoholic simple fatty liver[J]. Journal of Clinical Hepatology, 2013, 29(10): 756-759. doi: 10.3969/j.issn.1001-5256.2013.10.009

Supplements(0)

Cited By

Cited by

Periodical cited type(3)

1.	刘静媛. 超声瞬时弹性技术诊断慢性乙型肝炎患者肝纤维化的效能分析. 中国医疗器械信息. 2025(05): 104-106 .
2.	郑伟伟，俞慧，郑慧. 超声实时剪切波弹性成像、血清透明质酸对非酒精性脂肪性肝病的诊断价值. 中国现代医学杂志. 2024(08): 9-14 .
3.	鲍金霞，罗章梅. miR-654-3p、CHI3L1与不同中医证型慢性乙型肝炎合并非酒精性脂肪性肝病患者肝纤维化的关系. 四川中医. 2024(04): 104-108 .

Other cited types(2)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (905) PDF downloads(106)

Advances in the application of elastography in noninvasive diagnosis of liver fibrosis in nonalcoholic fatty liver disease

DOI: 10.3969/j.issn.1001-5256.2023.02.025